A ChIPchip approach reveals a novel role for transcription factor IRF1 in the DNA damage response

被引:48
作者
Frontini, Mattia [2 ]
Vijayakumar, Meeraa [1 ]
Garvin, Alexander [1 ]
Clarke, Nicole [1 ]
机构
[1] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England
[2] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Ctr Clin Sci, London W12 0NN, England
基金
英国生物技术与生命科学研究理事会;
关键词
REGULATORY FACTOR-I; FANCONI-ANEMIA; BREAST-CANCER; HUMAN PROMOTER; CROSS-LINKING; CPG ISLANDS; EXPRESSION; GENE; SUPPRESSOR; PROTEIN;
D O I
10.1093/nar/gkn1051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IRF1 is a transcription factor that regulates key processes in the immune system and in tumour suppression. To gain further insight into IRF1s role in these processes, we searched for new target genes by performing chromatin immunoprecipitation coupled to a CpG island microarray (ChIPchip). Using this approach we identified 202 new IRF1-binding sites with high confidence. Functional categorization of the target genes revealed a surprising cadre of new roles that can be linked to IRF1. One of the major functional categories was the DNA damage response pathway. In order to further validate our findings, we show that IRF1 can regulate the mRNA expression of a number of the DNA damage response genes in our list. In particular, we demonstrate that the mRNA and protein levels of the DNA repair protein BRIP1 [Fanconi anemia gene J (FANC J)] are upregulated after IRF1 over-expression. We also demonstrate that knockdown of IRF1 by siRNA results in loss of BRIP1 expression, abrogation of BRIP1 foci after DNA interstrand crosslink (ICL) damage and hypersensitivity to the DNA crosslinking agent, melphalan; a characteristic phenotype of FANC J cells. Taken together, our data provides a more complete understanding of the regulatory networks controlled by IRF1 and reveals a novel role for IRF1 in regulating the ICL DNA damage response.
引用
收藏
页码:1073 / 1085
页数:13
相关论文
共 73 条
[1]   Structure, function and evolution of CpG island promoters [J].
Antequera, F .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (08) :1647-1658
[2]   Norel inhibits tumor cell growth independent of Ras or the MST1/2 kinases [J].
Aoyama, Y ;
Avruch, J ;
Zhang, XF .
ONCOGENE, 2004, 23 (19) :3426-3433
[3]   Netrin-1 and its receptors in tumorigenesis [J].
Arakawa, H .
NATURE REVIEWS CANCER, 2004, 4 (12) :978-987
[4]   The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity [J].
Baer, R ;
Ludwig, T .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (01) :86-91
[5]   Peroxisome proliferator-activated receptor γ is a Zac target gene mediating Zac antiproliferation [J].
Barz, Thomas ;
Hoffmann, Anke ;
Panhuysen, Markus ;
Spengler, Dietmar .
CANCER RESEARCH, 2006, 66 (24) :11975-11982
[6]   T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects [J].
Beima, KM ;
Miazgowicz, MM ;
Lewis, MD ;
Yan, PS ;
Huang, THM ;
Weinmann, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (17) :11992-12000
[7]   Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells [J].
Bowie, ML ;
Dietze, EC ;
Delrow, J ;
Bean, GR ;
Troch, MM ;
Marjoram, RJ ;
Seewaldt, VL .
ONCOGENE, 2004, 23 (54) :8743-8755
[8]   BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function [J].
Cantor, SB ;
Bell, DW ;
Ganesan, S ;
Kass, EM ;
Drapkin, R ;
Grossman, S ;
Wahrer, DCR ;
Sgroi, DC ;
Lane, WS ;
Haber, DA ;
Livingston, DM .
CELL, 2001, 105 (01) :149-160
[9]   AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity [J].
Choi, MC ;
Jong, HS ;
Kim, TY ;
Song, SH ;
Lee, DS ;
Lee, JW ;
Kim, TY ;
Kim, NK ;
Bang, YJ .
ONCOGENE, 2004, 23 (42) :7095-7103
[10]   Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL [J].
Clarke, N ;
Jimenez-Lara, AM ;
Voltz, E ;
Gronemeyer, H .
EMBO JOURNAL, 2004, 23 (15) :3051-3060